Clinical Trials Directory

Trials / Unknown

UnknownNCT04491201

National Survey of the Impact of COVID-19 Pandemics

National Survey of the Impact of COVID-19 Pandemics on Chinese Physicians of Obstetrics and Gynecology

Status
Unknown
Phase
Study type
Observational
Enrollment
6,000 (estimated)
Sponsor
Lei Li · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

COVID-19 pandemics have changed extensively the lives around the world. Although most physicians of obstetrics and gynecology have no critical role in the frontline against COVID-19 pandemics, their work, research and education activities still underwent great changes. The primary aim of this study is to analyze change of workload during the COVID-19 pandemics in physicians of obstetrics and gynecology in China. A customized questionnaire will be delivered by the social software WeChat to the specific hospital which has been randomly sampled, and all physicians of Obstetrics and Gynecology in this hospital will fill the questionnaire anonymously. A random sampling will be performed in all 32 provinces, municipality or autonomous regions in the mainland of China. It is assumed that acceptable 95% confidence interval is P±4%, and the sample size under the condition of simple random sampling is 600 persons. If the homogeneity is set as 0.15 or 0.2, and each population (unit) has 10 or 15 persons accepting survey, we will achieve a design effect of 2.35 to 3.80. If we choose the design effect of 3, the sample size of every level needs is 1800. Considering 10% population refusing to be surveyed, in all mainland of China, three levels of hospitals will include at least 6000 physicians who accept survey.

Conditions

Interventions

TypeNameDescription
OTHERCustomized questionnaireA customized questionnaire will be delivered by the social software WeChat to the specific hospital which has been randomly sampled, and all physicians of Obstetrics and Gynecology in this hospital will fill the questionnaire anonymously.

Timeline

Start date
2020-07-27
Primary completion
2020-09-27
Completion
2020-09-27
First posted
2020-07-29
Last updated
2020-07-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04491201. Inclusion in this directory is not an endorsement.